Cargando…

Potential medicinal plants involved in inhibiting 3CL(pro) activity: A practical alternate approach to combating COVID-19

At present, a variety of vaccines have been approved, and existing antiviral drugs are being tested to find an effective treatment for coronavirus disease 2019 (COVID-19). However, no standardized treatment has yet been approved by the World Health Organization. The virally encoded chymotrypsin-like...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Fan, Jiang, Xiao-lan, Tariq, Akash, Sadia, Sehrish, Ahmed, Zeeshan, Sardans, Jordi, Aleem, Muhammad, Ullah, Riaz, Bussmann, Rainer W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shanghai Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. Published by Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359926/
https://www.ncbi.nlm.nih.gov/pubmed/35985974
http://dx.doi.org/10.1016/j.joim.2022.08.001
_version_ 1784764239264612352
author Yang, Fan
Jiang, Xiao-lan
Tariq, Akash
Sadia, Sehrish
Ahmed, Zeeshan
Sardans, Jordi
Aleem, Muhammad
Ullah, Riaz
Bussmann, Rainer W.
author_facet Yang, Fan
Jiang, Xiao-lan
Tariq, Akash
Sadia, Sehrish
Ahmed, Zeeshan
Sardans, Jordi
Aleem, Muhammad
Ullah, Riaz
Bussmann, Rainer W.
author_sort Yang, Fan
collection PubMed
description At present, a variety of vaccines have been approved, and existing antiviral drugs are being tested to find an effective treatment for coronavirus disease 2019 (COVID-19). However, no standardized treatment has yet been approved by the World Health Organization. The virally encoded chymotrypsin-like protease (3CL(pro)) from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which facilitates the replication of SARS-CoV in the host cells, is one potential pharmacological target for the development of anti-SARS drugs. Online search engines, such as Web of Science, Google Scholar, Scopus and PubMed, were used to retrieve data on the traditional uses of medicinal plants and their inhibitory effects against the SARS-CoV 3CL(pro). Various pure compounds, including polyphenols, terpenoids, chalcones, alkaloids, biflavonoids, flavanones, anthraquinones and glycosides, have shown potent inhibition of SARS-CoV-2 3CL(pro) activity with 50% inhibitory concentration (IC(50)) values ranging from 2–44 µg/mL. Interestingly, most of these active compounds, including xanthoangelol E (isolated from Angelica keiskei), dieckol 1 (isolated from Ecklonia cava), amentoflavone (isolated from Torreya nucifera), celastrol, pristimerin, tingenone and iguesterin (isolated from Tripterygium regelii), tannic acid (isolated from Camellia sinensis), and theaflavin-3,3′-digallate, 3-isotheaflav1in-3 gallate and dihydrotanshinone I (isolated from Salvia miltiorrhiza), had IC(50) values of less than 15 µg/mL. Kinetic mechanistic studies of several active compounds revealed that their mode of inhibition was dose-dependent and competitive, with K(i) values ranging from 2.4–43.8 μmol/L. Given the significance of plant-based compounds and the many promising results obtained, there is still need to explore the phytochemical and mechanistic potentials of plants and their products. These medicinal plants could serve as an effective inexpensive nutraceutical for the general public to help manage COVID-19.
format Online
Article
Text
id pubmed-9359926
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Shanghai Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-93599262022-08-09 Potential medicinal plants involved in inhibiting 3CL(pro) activity: A practical alternate approach to combating COVID-19 Yang, Fan Jiang, Xiao-lan Tariq, Akash Sadia, Sehrish Ahmed, Zeeshan Sardans, Jordi Aleem, Muhammad Ullah, Riaz Bussmann, Rainer W. J Integr Med Review At present, a variety of vaccines have been approved, and existing antiviral drugs are being tested to find an effective treatment for coronavirus disease 2019 (COVID-19). However, no standardized treatment has yet been approved by the World Health Organization. The virally encoded chymotrypsin-like protease (3CL(pro)) from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which facilitates the replication of SARS-CoV in the host cells, is one potential pharmacological target for the development of anti-SARS drugs. Online search engines, such as Web of Science, Google Scholar, Scopus and PubMed, were used to retrieve data on the traditional uses of medicinal plants and their inhibitory effects against the SARS-CoV 3CL(pro). Various pure compounds, including polyphenols, terpenoids, chalcones, alkaloids, biflavonoids, flavanones, anthraquinones and glycosides, have shown potent inhibition of SARS-CoV-2 3CL(pro) activity with 50% inhibitory concentration (IC(50)) values ranging from 2–44 µg/mL. Interestingly, most of these active compounds, including xanthoangelol E (isolated from Angelica keiskei), dieckol 1 (isolated from Ecklonia cava), amentoflavone (isolated from Torreya nucifera), celastrol, pristimerin, tingenone and iguesterin (isolated from Tripterygium regelii), tannic acid (isolated from Camellia sinensis), and theaflavin-3,3′-digallate, 3-isotheaflav1in-3 gallate and dihydrotanshinone I (isolated from Salvia miltiorrhiza), had IC(50) values of less than 15 µg/mL. Kinetic mechanistic studies of several active compounds revealed that their mode of inhibition was dose-dependent and competitive, with K(i) values ranging from 2.4–43.8 μmol/L. Given the significance of plant-based compounds and the many promising results obtained, there is still need to explore the phytochemical and mechanistic potentials of plants and their products. These medicinal plants could serve as an effective inexpensive nutraceutical for the general public to help manage COVID-19. Shanghai Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. Published by Elsevier B.V. 2022-11 2022-08-09 /pmc/articles/PMC9359926/ /pubmed/35985974 http://dx.doi.org/10.1016/j.joim.2022.08.001 Text en © 2022 Shanghai Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review
Yang, Fan
Jiang, Xiao-lan
Tariq, Akash
Sadia, Sehrish
Ahmed, Zeeshan
Sardans, Jordi
Aleem, Muhammad
Ullah, Riaz
Bussmann, Rainer W.
Potential medicinal plants involved in inhibiting 3CL(pro) activity: A practical alternate approach to combating COVID-19
title Potential medicinal plants involved in inhibiting 3CL(pro) activity: A practical alternate approach to combating COVID-19
title_full Potential medicinal plants involved in inhibiting 3CL(pro) activity: A practical alternate approach to combating COVID-19
title_fullStr Potential medicinal plants involved in inhibiting 3CL(pro) activity: A practical alternate approach to combating COVID-19
title_full_unstemmed Potential medicinal plants involved in inhibiting 3CL(pro) activity: A practical alternate approach to combating COVID-19
title_short Potential medicinal plants involved in inhibiting 3CL(pro) activity: A practical alternate approach to combating COVID-19
title_sort potential medicinal plants involved in inhibiting 3cl(pro) activity: a practical alternate approach to combating covid-19
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359926/
https://www.ncbi.nlm.nih.gov/pubmed/35985974
http://dx.doi.org/10.1016/j.joim.2022.08.001
work_keys_str_mv AT yangfan potentialmedicinalplantsinvolvedininhibiting3clproactivityapracticalalternateapproachtocombatingcovid19
AT jiangxiaolan potentialmedicinalplantsinvolvedininhibiting3clproactivityapracticalalternateapproachtocombatingcovid19
AT tariqakash potentialmedicinalplantsinvolvedininhibiting3clproactivityapracticalalternateapproachtocombatingcovid19
AT sadiasehrish potentialmedicinalplantsinvolvedininhibiting3clproactivityapracticalalternateapproachtocombatingcovid19
AT ahmedzeeshan potentialmedicinalplantsinvolvedininhibiting3clproactivityapracticalalternateapproachtocombatingcovid19
AT sardansjordi potentialmedicinalplantsinvolvedininhibiting3clproactivityapracticalalternateapproachtocombatingcovid19
AT aleemmuhammad potentialmedicinalplantsinvolvedininhibiting3clproactivityapracticalalternateapproachtocombatingcovid19
AT ullahriaz potentialmedicinalplantsinvolvedininhibiting3clproactivityapracticalalternateapproachtocombatingcovid19
AT bussmannrainerw potentialmedicinalplantsinvolvedininhibiting3clproactivityapracticalalternateapproachtocombatingcovid19